c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis (Q35993223)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 1, 1992

edit

Language	Label	Description	Also known as
English	c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis	scientific article published on October 1, 1992

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

title

c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

main subject

local neoplasm recurrence

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1358163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358163

retrieved

17 September 2022

proto-oncogene

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1358163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358163

retrieved

17 September 2022

author

Roelof Willighagen

series ordinal

4

object named as

Willighagen RG

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

Roelof Willighagen

series ordinal

4

object named as

R. G. Willighagen

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1358163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358163

retrieved

17 September 2022

author name string

C. A. Schroeter

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1358163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358163

retrieved

17 September 2022

C. R. De Potter

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1358163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358163

retrieved

17 September 2022

K. Rathsmann

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1358163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358163

retrieved

17 September 2022

J. C. Greep

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1358163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358163

retrieved

17 September 2022

language of work or name

English

0 references

publication date

1 October 1992

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

full work available at URL

https://europepmc.org/articles/PMC1977441

file format

HTML

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1358163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358163

retrieved

17 September 2022

https://europepmc.org/articles/PMC1977441?pdf=render

file format

Portable Document Format

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1358163

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1358163

retrieved

17 September 2022

published in

British Journal of Cancer

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

volume

66

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

issue

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

page(s)

728-734

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

cites work

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

The subcellular localization of the neu protein in human normal and neoplastic cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

The significance of oncogene amplification in primary breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

The long term prognostic significance of c-erbB-2 in primary breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

2 October 2017

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

Pattern of expression of c-erbB-2 oncoprotein in human fetuses

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

11 July 2018

Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977441

retrieved

23 September 2018

In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the c-erbB-2 protein in normal and transformed cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1358163

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BJC.1992.347

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

Fatcat ID

release_htwwyaqrwrdwtavznbv6khgnwa

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/htwwyaqrwrdwtavznbv6khgnwa

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1977441

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

PubMed publication ID

1358163

1 reference

stated in

Europe PubMed Central

PMC publication ID

1977441

retrieved

11 August 2017

ResearchGate publication ID

21797873

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35993223&oldid=2198041972"